A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders

Schizophrenia Bulletin

Volumn 39, Issue 3, 2013, Pages 658-672

  Mueser, Kim T ^a   Glynn, Shirley M ^b,c   Cather, Corrine ^d,e   Xie, Haiyi ^f,g   Zarate, Roberto ^c,h   Smith, Lindy Fox ^f,g   Clark, Robin E ⁱ   Gottlieb, Jennifer D ^a   Wolfe, Rosemarie ^f,g   Feldman, James ^e,j  

^a BOSTON UNIVERSITY   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

^g DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^h Pacific Clinics   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^j MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

more..

Author keywords

dual diagnosis; dual disorders; family psychoeducation; family therapy

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FAMILY THERAPY; FEMALE; HOSPITALIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL; SOCIAL PROBLEM; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; AGED; BIPOLAR DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FAMILY; FAMILY THERAPY; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876520640     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr203     Document Type: Article

References (73)

1. Archie S, Gyömörey K. First episode psychosis, substance abuse and prognosis: a systematic review. Curr Psychiatry Rev. 2009;5:153-163.
2. Drake RE, Brunette MF. Complications of severe mental illness related to alcohol and other drug use disorders. In: Galanter M, ed. Recent Developments in Alcoholism: Consequences of Alcoholism. Vol 14. New York, NY: Plenum Publishing Company; 1998:285-299.
3. Polcin DL. Issues in the treatment of dual diagnosis clients who have chronic mental illness. Prof Psychol Res Pract. 1992;23:30-37.
4. Ridgely MS, Goldman HH, Willenbring M. Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophr Bull. 1990;16:123-132. (Pubitemid 20110381)
5. Bachman KM, Moggi F, Hirsbrunner H-P, Donati R, Brodbeck J. An integrated treatment program for dually diagnosed patients. Psychiatr Serv. 1997;48:314-316. (Pubitemid 27113694)
6. Ekleberry SC. Integrated Treatment for Co-Occurring Disorders: Personality Disorders and Addiction. New York, NY: Routledge; 2008.
7. Graham HL, Copello A, Birchwood MJ, et al. Cognitive-Behavioural Integrated Treatment (C-BIT): A Treatment Manual for Substance Misuse in People with Severe Mental Health Problems. Chichester, England: John Wiley & Sons; 2004.
8. Mueser KT, Noordsy DL, Drake RE, Fox L. Integrated Treatment for Dual Disorders: A Guide to Effective Practice. New York, NY: Guilford Press; 2003.
9. Drake RE, O'Neal E, Wallach MA. A systematic review of psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34:123-138. (Pubitemid 350216356)
10. Kavanagh DJ, Mueser KT. Current evidence on integrated treatment for serious mental disorder and substance misuse. J Norwegian Psychol Assoc. 2007;5:618-637.
11. Cleary M, Hunt G, Matheson S, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse (Review). Cochrane Database Syst Rev. 2008; Issue 1. Art. No.: CD001088. DOI: 10.1002/14651858.CD001088.pub2. (Pubitemid 351807655)
12. James W, Preston NJ, Koh G, Spencer C, Kisely SR, Castle DJ. A group intervention which assists patients with dual diagnosis reduce their drug use: a randomised controlled trial. Psychol Med. 2004;34:983-990. (Pubitemid 39199968)
13. Jerrell JM, Ridgely MS. Comparative effectiveness of three approaches to serving people with severe mental illness and substance use disorders. J Nerv Ment Dis. 1995;183:566-576.
14. Weiss RD, Griffin ML, Jaffee WB, et al. A "communityfriendly" version of Integrated Group Therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend. 2009;104:212-219.
15. Barrowclough C, Haddock G, Wykes W, et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. Br Med J. 2010;341:c6325.
16. Kavanagh DJ, Young R, White A, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug Alcohol Rev. 2004;23:151-155. (Pubitemid 38907018)
17. Bellack AS, Bennet ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry. 2006;63:426-432.
18. Essock SM, Mueser KT, Drake RE, et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatr Serv. 2006;57:185-196. (Pubitemid 43214464)
19. Barrowclough C, Haddock G, Tarrier N, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry. 2001;158:1706-1713. (Pubitemid 32923666)
20. Clark RE, Drake RE. Expenditures of time and money by families of people with severe mental illness and substance use disorders. Commun Ment Health J. 1994;30:145-163. (Pubitemid 24116150)
21. Clark RE. Family support for persons with dual disorders. In: Drake RE, Mueser KT, eds. Dual Diagnosis of Major Mental Illness and Substance Abuse Volume 2: Recent Research and Clinical Implications. New Directions forMental Health Services. Vol 70. San Francisco, CA: Jossey-Bass; 1996:65-78.
22. Clark RE. Family support and substance use outcomes for persons with mental illness and substance use disorders. Schizophr Bull. 2001;27:93-101. (Pubitemid 32199266)
23. Fischer EP, McSweeney JC, Pyne JM, et al. Influence of family involvement and substance use on sustained utilization of services for schizophrenia. Psychiatr Serv. 2008;59:902-908.
24. Kashner M, Rader L, Rodell D, Beck C, Rodell L, Muller K. Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hosp Commun Psychiatry. 1991;42:195-197.
25. Perlick DA, Rosenheck RA, Kaczynski R, Swartz MS, Cañive JM, Lieberman JA. Components and correlates of family burden in schizophrenia. Psychiatr Serv. 2006;57:1117-1125. (Pubitemid 44204904)
26. Dixon L, McNary S, Lehman A. Substance abuse and family relationships of persons with severe mental illness. Am J Psychiatry. 1995;152:456-458.
27. Niv N, Lopez SR, Glynn SM, Mueser KT. The role of substance use in families, attributions and affective reactions to their relative with severe mental illness. J Nerv Ment Dis. 2007;195:307-314. (Pubitemid 46624823)
28. Salyers MP, Mueser KT. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res. 2001;48:109-123. (Pubitemid 32241187)
29. Caton CLM, Shrout PE, Dominguez B, Eagle PF, Opler LA, Cournos F. Risk factors for homelessness among women with schizophrenia. Am J Public Health. 1995;85:1153-1156.
30. Caton CLM, Shrout PE, Eagle PF, Opler LA, Felix A. Correlates of codisorders in homeless and never homeless indigent schizophrenic men. Psychol Med. 1994;24:681-688. (Pubitemid 24265751)
31. Falloon IRH, Boyd JL, McGill CW. Family Care of Schizophrenia: A Problem-Solving Approach to the Treatment of Mental Illness. New York, NY: Guilford Press; 1984.
32. Mueser KT, Glynn SM. Behavioral Family Therapy for Psychiatric Disorders. 2nd ed. Oakland, CA: New Harbinger; 1999.
33. Mueser KT, Fox L. A family intervention program for dual disorders. Commun Ment Health J. 2002;38:253-270. (Pubitemid 38457405)
34. Mueser KT, Glynn SM, Cather C, et al. Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addict Behav. 2009;34:867-877.
35. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis-I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
36. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen J, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992:41-72.
37. Carey KB, Carey MP, Maisto SA, Henson JM. Temporal stability of the Timeline Followback Interview for alcohol and drug use with psychiatric outpatients. J Stud Alcohol. 2004;65:774-781. (Pubitemid 40096941)
38. Mueser KT, Drake RE, Clark RE, McHugo GJ, Mercer-McFadden C, Ackerson T. Toolkit for Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Evaluation Center at HSRI; 1995.
39. McHugo GJ, Drake RE, Burton HL, Ackerson TH. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. J Nerv Ment Dis. 1995;183:762-767.
40. Drake RE, Mueser KT, McHugo GJ. Clinician Rating Scales: Alcohol Use Scale (AUS), Drug Use Scale (DUS), and Substance Abuse Treatment Scale (SATS). In: Sederer LI, Dickey B, eds. Outcomes Assessment in Clinical Practice. Baltimore, MD: Williams & Wilkins; 1996:113-116.
41. Lukoff D, Nuechterlein KH, Ventura J. Manual for the Expanded Brief Psychiatric Rating Scale (BPRS). Schizophr Bull. 1986;12:594-602.
42. Velligan D, Prihoda T, Dennehy E, et al. Brief Psychiatric Rating Scale Expanded Version: how do new items affect factor structure? Psychiatry Res. 2005;135:217-228.
43. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
44. McGill CW, Falloon IRH, Boyd JL, Wood-Siverio C. Family educational intervention in the treatment of schizophrenia. Hosp Commun Psychiatry. 1983;34:934-938. (Pubitemid 14236971)
45. D'Zurilla TJ, Nezu AM. Development and preliminary evaluation of the Social Problem-Solving Inventory. Psychol Assess. 1990;2:156-163.
46. Ware JEJ, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. 3rd ed. Lincoln, RI: Quality Metric, Inc.; 1998.
47. Tessler R, Gamache G. Toolkit for Evaluating Family Experiences with Severe Mental Illness. Amherst, MA: The Evaluation Center at HSRI; 1996.
48. Hooley JM. Expressed emotion and relapse of psychopathology. Annu Rev Clin Psychol. 2007;3:329-352. (Pubitemid 46651132)
49. Osher FC, Kofoed LL. Treatment of patients with psychiatric and psychoactive substance use disorders. Hosp Commun Psychiatry. 1989;40:1025-1030. (Pubitemid 19257767)
50. Prochaska JO. Systems of Psychotherapy: A Transtheoretical Analysis. Homewood, IL: Dorsey; 1984.
51. Schooler NR, Keith SJ, Severe JB, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment. Arch Gen Psychiatry. 1997;54:453-463. (Pubitemid 27198207)
52. Stanton MD, Shadish WR. Outcome, attrition, and familycouples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull. 1997;122:170-191. (Pubitemid 127705310)
53. Borenstein M, Rothstein H, Cohen J. Sample Power, Release SPSS Inc. 1997.
54. SAS Institute Inc. SAS/STAT User's guide, Version 9.2. Cary, NC: SAS Institute Inc.; 2008.
55. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. 2nd ed. New York, NY: John Wiley & Sons; 2011.
56. Hedeker D, Gibbons RD. Longitudinal Data Analysis. New York, NY: Wiley; 2006.
57. Jennrich R, Schluchter M. Unbalanced repeated-measures models with structured covariance matrices. Biometrics. 1986;42:805-820. (Pubitemid 17134900)
58. Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. Oxford, UK: Oxford Science Publications; 2002.
59. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health. 1993;14:43-68. (Pubitemid 23161711)
60. Drake RE, McHugo GJ, Clark RE, et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry. 1998;68:201-215. (Pubitemid 28215537)
61. Falloon IRH, McGill CW, Boyd JL, Pederson J. Family management in the prevention of morbidity of schizophrenia: social outcome of a two-year longitudinal study. Psychol Med. 1987;17:59-66. (Pubitemid 17055154)
62. Giron M, Fernandez-Yanez A, Mana-Alvarenga S, Molina-Habas A, Nolasco A, Gomez-Beneyto M. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study. Psychol Med. 2010;40:73-84.
63. Hazel NA, McDonell MG, Short RA, et al. Impact of multiple-family groups for outpatients with schizophrenia on caregivers' distress and resources. Psychiatr Serv. 2004; 55:35-41. (Pubitemid 38045013)
64. Xiong W, Phillips MR, Hu X, et al. Family-based intervention for schizophrenic patients in China: a randomised controlled trial. Br J Psychiatry. 1994;165:239-247. (Pubitemid 24259351)
65. Walsh F. Family resilience: a collaborative approach in response to stressful life challenges. In: Southwick SM, Litz BT, Charney D, Friedman MJ, eds. Resilience and Mental Health: Challenges Across the Lifespan. Cambridge, UK: Cambridge University Press; 2011:149-161.
66. Haddock G, Barrowclough C, Tarrier N, et al. Cognitivebehavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. Br J Psychiatry. 2003;183:418-426. (Pubitemid 37357574)
67. Barrowclough C, Tarrier N. Social functioning and family interventions. In: Mueser KT, Tarrier N, eds. Handbook of Social Functioning in Schizophrenia. Boston, MA: Allyn & Bacon; 1998:327-341.
68. Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2010; (12, Art. No.: CD000088).
69. Pitschel-Walz G, Leucht S, Bäuml J, Kissling W, Engel RR. The effect of family interventions on relapse and rehospitalization in schizophrenia: a meta-analysis. Schizophr Bull. 2001;27:73-92. (Pubitemid 32199265)
70. Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat. 2001;55:19-24.
71. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006;63:484-489.
72. Lenth RV. Some practical guidelines for effective sample size determination. Am Stat. 2001;55:187-193.
73. Mueser KT, Gingerich SL, Rosenthal CK. Educational family therapy for schizophrenia: a new treatment model for clinical service and research. Schizophr Res. 1994;13:99-108.